Consuming a high-carbohydrate load may have an acute and detrimental effect on heart function, according to a study published in the Journal of the American College of Cardiology.
Mar 25, 2016
0
1862
People with psoriasis and psoriatic arthritis, collectively known as psoriatic disease, are more likely to develop cardiovascular disease than others in the general population. In a new study published in Arthritis & Rheumatology ...
Mar 9, 2022
0
5
A hormone found in the blood that's commonly linked to heart disease also might signal when someone is more likely to grow weaker or lose their ability to balance before they're 70.
Jan 22, 2019
1
16
Assessing preoperative levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), a biomarker of heart stress and structural changes, may improve risk prediction beyond the clinical risk score in patients having noncardiac ...
Dec 25, 2019
0
3
Researchers at the University of Birmingham have found two biomarkers that could be used to identify a heart condition known as atrial fibrillation in patients who have three 'clinical risks'.
Jan 7, 2019
0
89
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes. The analysis, conducted by 23 experts ...
Jan 25, 2024
0
24
A simple blood test may predict the risk of progressive heart and kidney disease in people with type 2 diabetes and kidney disease, according to new research published in the journal Circulation.
Aug 21, 2023
0
5
In a recent study published in the Journal of the American Heart Association by University of Alabama at Birmingham researchers, findings indicate that among patients with heart failure, obesity is associated with a higher ...
Apr 5, 2021
0
51
Empagliflozin reduces the risk of a composite of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction (HFpEF) with or without diabetes. That's the finding ...
Aug 27, 2021
0
176
Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid cardiomyopathy, according to a study published ...
Jan 14, 2024
0
6
